Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Epigenome analysis of ependymoma cell lines

ABSTRACT: Epigenome analysis of ependymoma cell lines

PROVIDER: PRJNA436983 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma

Project description:PFA ependymomas are a lethal glial malignancy of the hindbrain found in babies and toddlers. Lacking any highly recurrent somatic mutations, PFAs have been proposed as a largely epigenetically driven tumor type. An almost complete lack of model systems has inhibited discovery of novel PFA therapies. Both in vitro and in vivo, the PFA hypoxic microenvironment controls the availability of specific metabolites to diminish histone methylation, and to increase both histone demethylation and acetylation at H3K27. PFA ependymoma initiates from a cell lineage in the first trimester of human development where there is a known hypoxic microenvironment. Unique to PFA cells, transient exposure to ambient oxygen results in irreversible cellular toxicity. PFA tumors exhibit a low basal level of H3K27me3, and paradoxically inhibition of H3K27 methylation shows significant and specific activity against PFA. Targeting metabolism and/or the epigenome presents a unique opportunity for rational therapy for infants with PFA ependymoma.

2020-08-13 | PXD018191 | Pride

Epigenome analysis of Sorafenib-resistant huh7 cell lines

Project description:Epigenome analysis of Sorafenib-resistant huh7 cell lines

| PRJNA877200 | ENA

Epigenome analysis of apoptotic and control cancer cell lines

Project description:Epigenome analysis of apoptotic and control cancer cell lines

| PRJNA854182 | ENA

Epigenome analysis of ependymoma cell lines

Project description:DNA methylation profiling using Illumina Infinium HumanMethylation450 BeadChip arrays was used to assign cell lines to previously defined subgroups.

2018-12-07 | GSE111428 | GEO

Analysis of reprogramming of epigenome in TET1 knockdown cancer cell lines

Project description:Analysis of reprogramming of epigenome in TET1 knockdown cancer cell lines

| PRJNA498005 | ENA

Epigenome analysis of parental and ABT-199 resistant AML cell lines

Project description:Epigenome analysis of parental and ABT-199 resistant AML cell lines

| PRJNA795503 | ENA

Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma

Project description:Posterior fossa type A (PFA) ependymomas are a lethal glial malignancy of the hindbrain found in babies and toddlers. Lacking any highly recurrent somatic mutations, PFAs have been proposed as a largely epigenetically driven tumor type. An almost complete lack of model systems has inhibited discovery of novel PFA therapies. Both in vitro and in vivo, the PFA hypoxic microenvironment controls the availability of specific metabolites to diminish histone methylation, and to increase both histone demethylation and acetylation at H3K27. PFA ependymoma initiates from a cell lineage in the first trimester of human development where there is a known hypoxic microenvironment. Unique to PFA cells, transient exposure to ambient oxygen results in irreversible cellular toxicity. PFA tumors exhibit a low basal level of H3K27me3, and paradoxically inhibition of H3K27 methylation shows significant and specific activity against PFA. Targeting metabolism and/or the epigenome presents a unique opportunity for rational therapy for infants with PFA ependymoma.

2020-07-08 | GSE146426 | GEO

Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma

Project description:Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma

| PRJNA610567 | ENA

Metabolic regulation of the epigenome drives lethal infantile ependymoma [Cut&Run]

Project description:PFA (posterior fossa group A) ependymomas are a lethal glial malignancy of the hindbrain found in infants and toddlers. Lacking any highly recurrent somatic mutations, PFAs have been proposed as a largely epigenetically driven tumor type. An almost complete lack of model systems has inhibited discovery of novel PFA therapies. Both in vitro and in vivo, the PFA hypoxic microenvironment controls the availability of specific metabolites to diminish histone methylation, and to increase both histone demethylation and acetylation at H3K27. PFA ependymoma initiates from a cell lineage in the first trimester of human development where there is a known hypoxic microenvironment. Unique to PFA cells, transient exposure to ambient oxygen results in irreversible cellular toxicity. PFA tumors exhibit a low basal level of H3K27me3, and paradoxically inhibition of H3K27 methylation shows significant and specific activity against PFA. Targeting metabolism and/or the epigenome presents a unique opportunity for rational therapy for infants with PFA ependymoma.

2020-03-18 | GSE146858 | GEO

Epigenome analysis of glioma patient surgical samples and corresponding xenotransplants and cell lines

Project description:Epigenome analysis of glioma patient surgical samples and corresponding xenotransplants and cell lines

| PRJNA573660 | ENA